Cargando…
The therapeutic dilemma of immunosuppressive drugs for refractory cardiac sarcoidosis in COVID‐19 infection
Patients with refractory cardiac sarcoidosis (CS) take a high dose of corticosteroid and immunosuppressive agents. During the pandemic outbreak of severe acute respiratory syndrome coronavirus 2, appropriate treatment of corticosteroids or immunosuppressive agents in CS patients with coronavirus dis...
Autores principales: | Goto, Kohsaku, Uehara, Masae, Okamoto, Koh, Takeda, Norifumi, Morita, Hiroyuki, Hatano, Masaru, Komuro, Issei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653200/ https://www.ncbi.nlm.nih.gov/pubmed/34697891 http://dx.doi.org/10.1002/ehf2.13676 |
Ejemplares similares
-
Acute cellular rejection after heart transplantation and its remission visualized by cardiac magnetic resonance
por: Dai, Zhehao, et al.
Publicado: (2021) -
Coronary Periarteritis and Pericardial Thickening Could Be Predictors for Coronary Artery Events Complicated by IgG4-Related Disease
por: Yagi, Hiroki, et al.
Publicado: (2023) -
Progressive Right Ventricular Aneurysm in a Patient with Systemic Sarcoidosis
por: Hirose, Kazutoshi, et al.
Publicado: (2019) -
Cholecystitis and Cholangitis during Continuous Renal Replacement Therapy in a Patient with Retroperitoneal Hemorrhage Requiring Large Amounts of Contrast Medium for the Assessment and Intervention
por: Goto, Kohsaku, et al.
Publicado: (2022) -
The effect of immunosuppressive therapy on cardiac involvements in anti‐mitochondrial antibody‐positive myositis
por: Bujo, Satoshi, et al.
Publicado: (2022)